Vaccine factory goes up fast; large volume expected
Share - WeChat
A new factory producing COVID-19 vaccines started up in Wuhan, Hubei province, on Monday after 86 days of construction, the builder said.
It is the second phase of vaccine production affiliated with the Wuhan Institute of Biological Productions Co of Sinopharm, a State-owned pharmaceutical company. It has a designed annual production capacity of 1 billion doses, according to a statement by China Construction Third Engineering Bureau Group, the second phase builder.
The new factory is expected to produce 600 million vaccine doses for COVID-19 by the end of this year.
Related Stories
- China to speed up revisions of food safety standards
- Ancient observatory in Xizang marks spring sowing season with rituals
- NPC deputy calls for national policy to integrate sports and tourism
- NPC deputy: Automation shifts workers to smarter roles
- Chinese scientists develop 'double-sided tape' to boost CAR-T leukemia therapy
- Cold front sweeps east across China, bringing snow and sandstorms
































